JAZZ insider transaction filings
Jazz Pharmaceuticals plc — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-07. Screen JAZZ transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-07 | 4 | Pearce Samantha — EVP, Chief Commercial Officer | Tax withholding (F): 780 @ $261.62 | EDGAR |
| 2026-08-07 | 4 | Winningham Rick E — Director | Grant/award (A): 1,605 @ $0 | EDGAR |
| 2026-08-07 | 4 | LOVE TED W — Director | Grant/award (A): 1,605 @ $0 | EDGAR |
| 2026-08-07 | 4 | Kennedy Patrick — Director | Grant/award (A): 1,605 @ $0 | EDGAR |
| 2026-08-07 | 4 | Hamill Laura — Director | Grant/award (A): 1,605 @ $0 | EDGAR |
| 2026-08-07 | 4 | Smith Mark Douglas — Director | Grant/award (A): 1,605 @ $0 | EDGAR |
| 2026-08-07 | 4 | Cook Jennifer E. — Director | Grant/award (A): 1,605 @ $0 | EDGAR |
| 2026-08-07 | 4 | Mulligan Seamus — Director | Grant/award (A): 1,605 @ $0 | EDGAR |
| 2026-08-07 | 4 | ENRIGHT PATRICK G — Director | Grant/award (A): 1,605 @ $0 | EDGAR |
| 2026-08-07 | 4 | McSharry Heather Ann — Director | Grant/award (A): 1,605 @ $0 | EDGAR |
| 2026-08-07 | 4 | COZADD BRUCE C — Director | Grant/award (A): 1,605 @ $0 | EDGAR |
| 2026-08-07 | 4 | RIEDEL NORBERT G — Director | Grant/award (A): 1,605 @ $0 | EDGAR |
| 2026-08-05 | 4 | COZADD BRUCE C — Director | Sale (S): 6,000 @ $252.98 | EDGAR |
| 2026-07-06 | 4 | COZADD BRUCE C — Director | Sale (S): 6,000 @ $240.47 | EDGAR |
| 2026-07-02 | 4 | Johnson Philip L — EVP & Chief Financial Officer | Tax withholding (F): 3,343 @ $237.72 | EDGAR |
| 2026-07-02 | 4 | Pearce Samantha — EVP, Chief Commercial Officer | Tax withholding (F): 2,527 @ $237.72 | EDGAR |
| 2026-07-02 | 4 | Patil Neena M — EVP & Chief Legal Officer | Tax withholding (F): 2,678 @ $237.72 | EDGAR |
| 2026-07-02 | 4 | Iannone Robert — EVP, Global Head of R&D & CMO | Tax withholding (F): 3,764 @ $237.72 | EDGAR |
| 2026-07-02 | 4 | GALA RENEE D — President & CEO | Tax withholding (F): 4,835 @ $237.72 | EDGAR |
| 2026-06-17 | 4 | Smith Mark Douglas — Director | Sale (S): 1,157 @ $230.55 | EDGAR |
| 2026-06-12 | 4 | Patil Neena M — EVP & Chief Legal Officer | Sale (S): 1,200 @ $231.83 | EDGAR |
| 2026-06-05 | 4 | GALA RENEE D — President & CEO | Gift (G): 600 @ $0 | EDGAR |
| 2026-06-03 | 4 | COZADD BRUCE C — Director | Sale (S): 6,000 @ $235.12 | EDGAR |
| 2026-06-01 | 4 | Pearce Samantha — EVP, Chief Commercial Officer | Option exercise (M): 6,907 @ $109.45 · Sale (S): 6,907 @ $235.41 · Option exercise (M): 6,907 (derivative) @ $0 | EDGAR |
| 2026-06-01 | 4 | Patil Neena M — EVP & Chief Legal Officer | Sale (S): 1,192 @ $236.97 | EDGAR |
| 2026-06-01 | 4 | Mulligan Seamus — Director | Option exercise (M): 3,415 @ $138.08 · Option exercise (M): 3,415 (derivative) @ $0 | EDGAR |
| 2026-05-27 | 4 | McSharry Heather Ann — Director | Sale (S): 2,000 @ $241 | EDGAR |
| 2026-05-27 | 4 | Winningham Rick E — Director | Option exercise (M): 3,415 @ $138.08 · Sale (S): 2,741 @ $241.57 · Option exercise (M): 3,415 (derivative) @ $0 | EDGAR |
| 2026-05-05 | 4 | COZADD BRUCE C — Director | Sale (S): 6,000 @ $203.33 | EDGAR |
| 2026-04-03 | 4 | COZADD BRUCE C — Director | Sale (S): 3,684 @ $190.22 · Sale (S): 2,292 @ $190.94 · Sale (S): 24 @ $191.74 | EDGAR |
| 2026-03-09 | 4 | Johnson Philip L — EVP & Chief Financial Officer | Tax withholding (F): 2,615 @ $188.69 | EDGAR |
| 2026-03-09 | 4 | Henderson Mary Elizabeth — SVP, Technical Operations | Tax withholding (F): 1,394 @ $186.75 | EDGAR |
| 2026-03-09 | 4 | Pearce Samantha — EVP, Chief Commercial Officer | Tax withholding (F): 2,503 @ $188.69 | EDGAR |
| 2026-03-09 | 4 | Carr Patricia — SVP, Chief Accounting Officer | Tax withholding (F): 1,436 @ $186.77 · Sale (S): 1,287 @ $182.94 | EDGAR |
| 2026-03-09 | 4 | Patil Neena M — EVP & Chief Legal Officer | Tax withholding (F): 5,000 @ $188.69 | EDGAR |
| 2026-03-09 | 4 | Iannone Robert — EVP, Global Head of R&D & CMO | Tax withholding (F): 6,209 @ $188.69 | EDGAR |
| 2026-03-09 | 4 | GALA RENEE D — President & CEO | Tax withholding (F): 7,065 @ $188.69 | EDGAR |
| 2026-03-09 | 4 | COZADD BRUCE C — Director | Tax withholding (F): 15,114 @ $188.69 | EDGAR |
| 2026-03-04 | 4 | COZADD BRUCE C — Director | Sale (S): 3,159 @ $186.09 · Sale (S): 2,608 @ $186.73 · Sale (S): 233 @ $187.84 | EDGAR |
| 2026-03-02 | 4 | Johnson Philip L — EVP & Chief Financial Officer | Grant/award (A): 11,857 @ $0 | EDGAR |
| 2026-03-02 | 4 | Henderson Mary Elizabeth — SVP, Technical Operations | Grant/award (A): 4,447 @ $0 · Sale (S): 5,343 @ $194.49 | EDGAR |
| 2026-03-02 | 4 | Pearce Samantha — EVP, Chief Commercial Officer | Grant/award (A): 9,782 @ $0 | EDGAR |
| 2026-03-02 | 4 | Carr Patricia — SVP, Chief Accounting Officer | Grant/award (A): 2,223 @ $0 · Sale (S): 1,253 @ $194.11 · Sale (S): 1,117 @ $190.91 | EDGAR |
| 2026-03-02 | 4 | Patil Neena M — EVP & Chief Legal Officer | Option exercise (M): 20,125 @ $113.10 · Sale (S): 16,602 @ $192.53 · Option exercise (M): 875 @ $113.10 · Sale (S): 875 @ $192.07 · Option exercise (M): 27,084 @ $137.12 · Sale (S): 15,555 @ $190.28 · +14 more | EDGAR |
| 2026-03-02 | 4 | Iannone Robert — EVP, Global Head of R&D & CMO | Grant/award (A): 14,822 @ $0 | EDGAR |
| 2026-03-02 | 4 | GALA RENEE D — President & CEO | Grant/award (A): 44,465 @ $0 | EDGAR |
| 2026-03-02 | 4 | LOVE TED W — Director | Grant/award (A): 1,527 @ $0 | EDGAR |
| 2026-03-02 | 4 | RIEDEL NORBERT G — Director | Option exercise (M): 3,415 @ $138.08 · Sale (S): 3,415 @ $192 · Option exercise (M): 3,415 (derivative) @ $0 | EDGAR |
| 2026-01-21 | 4 | Henderson Mary Elizabeth — SVP, Technical Operations | Grant/award (A): 10,116 @ $0 | EDGAR |
| 2026-01-21 | 4 | Pearce Samantha — EVP, Chief Commercial Officer | Grant/award (A): 3,637 @ $0 · Tax withholding (F): 1,599 @ $171.16 | EDGAR |
Recent 8-K events — Jazz Pharmaceuticals plc
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-10 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-10 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-03 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-24 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-29 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-05-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-24 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-17 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=JAZZ returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →